AI assistant
Sending…
STREAMPLAY STUDIO LIMITED — Director's Dealing 2007
Dec 2, 2007
65841_rns_2007-12-02_c248a260-8a22-421b-a340-9ff11d633ae5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
| Name of entity: | GIPPSLAND LIMITED |
|---|---|
| ABN: | 31 004 766 376 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | JON STARINK |
|---|---|
| Date of last notice | 9 May 2007 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrisetotherelevant interest. | Fully paid ordinary shares purchased by Lazarus FoundationPty Ltd ATF Rand Trust. Jon Starink is a director of theLazarus Foundation Pty Ltd and a beneficiary of the RandTrust. |
| Date of change | 28 November 2007 |
| No. of securities held prior to change | Nil |
| Class | Fully paid ordinary shares |
| Number acquired | 300,000 |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation | $32,500 |
| No. of securities held after change | 300,000 |
| Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back | On market trade |
Part 2 – Change of director’s interests in contracts – N/A
- See chapter 19 for defined terms. 11/3/2002
Appendix 3Y Page 1
More from STREAMPLAY STUDIO LIMITED
Regulatory Filings
2026
Jun 4
Interim / Quarterly Report
2026
Apr 27
Regulatory Filings
2026
Apr 21
Share Issue/Capital Change
2026
Apr 20
Interim / Quarterly Report
2026
Feb 25
Interim / Quarterly Report
2026
Feb 25
Interim / Quarterly Report
2026
Jan 27
Regulatory Filings
2026
Jan 11
Director's Dealing
2025
Dec 30
Share Issue/Capital Change
2025
Dec 23